1. Clinical Overview
A topical oral solution combining a non-steroidal anti-inflammatory drug (NSAID) derivative, choline salicylate, with an astringent and protein precipitant, tannic acid. It is primarily indicated for the symptomatic relief of pain and inflammation associated with minor mouth and throat conditions. Choline salicylate provides analgesic and anti-inflammatory action, while tannic acid acts as an astringent to tighten tissues, reduce inflammation, and provide a protective coating over irritated mucous membranes.
| Onset | Duration | Bioavailability |
|---|---|---|
| Topical analgesic effect begins within 2-5 minutes of application. | Local analgesic effect typically lasts for 2-3 hours. | Systemic absorption of choline salicylate from the oral mucosa is variable and generally low (<10-15%) when used as directed for gargling/rinse, but can be significant if swallowed. Tannic acid has minimal systemic absorption. |
2. Mechanism of Action
Choline Salicylate: Upon topical application, it is hydrolyzed to release salicylic acid. Salicylates inhibit the cyclooxygenase (COX) enzymes, COX-1 and COX-2, thereby reducing the synthesis of prostaglandins (PGs) and thromboxanes from arachidonic acid. This inhibition decreases the sensitization of pain receptors (nociceptors) to mechanical and chemical stimuli and reduces inflammatory mediators at the site of application, providing local analgesic and anti-inflammatory effects. Tannic Acid: Acts as an astringent by precipitating proteins on the surface of the inflamed or ulcerated oral mucosa. This forms a protective layer or coat, which reduces permeability, shrinks and constricts tissues, decreases local exudation, and provides a soothing effect. It also has mild antibacterial properties.
3. Indications & Uses
- Symptomatic relief of pain and inflammation in minor mouth and throat infections (e.g., pharyngitis, tonsillitis)
- Pain relief from mouth ulcers (aphthous ulcers/canker sores)
- Gingival inflammation (gingivitis)
- Teething pain in infants and children (with extreme caution and medical advice)
4. Dosage & Administration
Adult Dosage: Gargle or rinse with 10-15 mL (approximately 2-3 teaspoonfuls) of the undiluted solution for 1-2 minutes, then spit out. Do not swallow. Use every 3-4 hours as needed, not to exceed 8 times in 24 hours.
Administration: 1. Shake the bottle well before use. 2. Measure the recommended quantity using the cap or a measuring cup. 3. Gargle or rinse thoroughly, ensuring contact with all affected areas for 1-2 minutes. 4. SPIT OUT COMPLETELY. DO NOT SWALLOW. 5. Avoid eating or drinking for at least 15-20 minutes after application to allow the medicine to work. 6. Do not use for more than 7 days unless directed by a physician.
5. Side Effects
Common side effects may include:
- Localized burning or stinging sensation at the application site
- Temporary numbness or altered taste perception
- Discoloration of teeth or tongue (brownish stain from tannic acid, usually reversible)
- Dryness of mouth
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Anticoagulants (Warfarin, Acenocoumarol) | Increased risk of bleeding due to additive antiplatelet effect and potential displacement from protein binding sites. | Major - Contraindicated |
| Other NSAIDs (Ibuprofen, Diclofenac) | Increased risk of GI side effects and bleeding. No additional therapeutic benefit. | Major |
| Methotrexate | Salicylates can decrease renal clearance of methotrexate, increasing its toxicity (myelosuppression). | Major |
| Sulfonylureas (Glibenclamide, Glimepiride) | Salicylates may potentiate hypoglycemic effect. | Moderate |
| Valproic Acid | Salicylates can displace valproic acid from protein binding, increasing free drug levels and risk of toxicity. | Moderate |
| Corticosteroids (e.g., Prednisolone) | Increased risk of GI ulceration. Steroids may reduce salicylate levels. | Moderate |
| ACE Inhibitors (e.g., Enalapril) | Salicylates may diminish the antihypertensive effect. | Moderate |
| Diuretics | Salicylates may reduce the efficacy of loop diuretics (furosemide) and thiazides. Risk of dehydration and renal impairment. | Moderate |
| Probenecid | Salicylates antagonize the uricosuric effect of probenecid. | Moderate |
7. Patient Counselling
- DO gargle or rinse as directed and spit out completely.
- DO shake the bottle well before use.
- DO use after meals to help relieve pain associated with eating.
- DO maintain good oral hygiene but avoid brushing directly over ulcers immediately after application.
- DO contact your doctor if symptoms worsen or do not improve within 3 days.
- DO NOT SWALLOW the medication.
- DO NOT use for more than 7 days without consulting your doctor.
- DO NOT give to children under 12 years unless specifically prescribed by a pediatrician.
- DO NOT use if you are allergic to aspirin or other salicylates.
- DO NOT use with other NSAID-containing medicines without asking your doctor.
8. Toxicology & Storage
Overdose: Acute Salicylate Toxicity (Salicylism): Mild: Nausea, vomiting, tinnitus, vertigo, hyperventilation, sweating. Moderate: Severe tinnitus, deafness, blurred vision, lethargy, fever. Severe: Severe metabolic acidosis, respiratory alkalosis, cerebral and pulmonary edema, seizures, coma, renal failure, cardiovascular collapse. Chronic Toxicity: Can occur with repeated topical overuse, especially in children or elderly.
Storage: Store at room temperature (15-25°C), protected from light and excessive heat. Keep the bottle tightly closed. Keep out of reach of children and pets. Do not freeze. Do not use after the expiry date printed on the label. Discard any unused solution 4 weeks after opening the bottle to prevent microbial contamination.